AGP Executive Report
Last update: 11 hours agoBiotech Spotlight: Akeso (9926.HK) is set to flood ASCO 2026 with 40+ oncology studies, including an LBA in the plenary session and Phase III HARMONi-6 overall survival data for ivonescimab plus chemo in first-line sq-NSCLC. Market Mood: Hong Kong’s recovery still looks “incomplete,” the IMF says, with activity below pre-pandemic trend and headwinds from weak private investment and labour participation. Finance Policy Shock: China is tightening controls on overseas stock trading, cracking down on offshore brokerage activity—raising the stakes for cross-border capital flows that Hong Kong intermediaries depend on. Aviation & Infrastructure: Airport Authority Hong Kong has reopened rebuilt Terminal 2, with airlines shifting check-in operations through mid-June as carriers reroute away from the Middle East. Healthcare Deal: Jardine Matheson is buying Australia’s I-MED Radiology Network for A$3.4b (US$2.4b), adding AI-enabled radiology ambitions. Tech & Industry: IDI Dynamics (ISDN) launched a high-speed laser marker for semiconductor OSAT, promising 2.5x throughput in a smaller footprint. Energy/Geopolitics: US-Iran “self-defence” strikes keep Hormuz-deal hopes fragile, leaving Asian stocks mixed and gold/silver easing on inflation jitters.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result.
Perspectify News
